III:LSE3i Group plc Analysis
Data as of 2026-06-14 - not real-time
£2,309.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
III is trading at roughly £23.09 per share, well below its DCF‑derived fair value of £43.71, implying a potential upside of over 45 %. The stock’s trailing P/E of 4.28 is dramatically lower than the asset‑management industry average of 16.83, underscoring a deep valuation discount. A dividend yield of 3.66 % combined with a modest payout ratio of 14.7 % suggests the dividend is comfortably sustainable. Recent results show a 22 % total return for FY‑2026 and NAV per share up 19 % to £30.30, driven by strong performance in the Action retailer and private‑equity portfolios. On the technical side, the 20‑day SMA (2,218) sits above price, while the 50‑day (2,466) and 200‑day (3,260) SMAs remain well above, indicating a long‑term bearish backdrop. However, the MACD histogram is positive and the MACD signal is bullish, hinting at short‑term momentum improvement near the current resistance of 2,364.
Volatility remains high at 58 % over the past 30 days and the max drawdown exceeds 53 %, reflecting sizable price swings. The beta of 0.90 points to lower systematic risk than the market, while decreasing volume may limit short‑term liquidity. The company’s debt‑to‑equity ratio of 4.08 is elevated, but strong operating cash flow and a free cash flow generation of £3.39 bn support balance‑sheet resilience. The sector’s regulatory environment and broad geographic exposure introduce moderate regulatory and geographic risks. Overall, the combination of a sizable valuation gap, solid earnings, and a sustainable dividend outweighs the technical bearish trend in the medium‑term view. Investors should therefore consider a measured entry, capitalising on upside potential while monitoring technical levels.
Volatility remains high at 58 % over the past 30 days and the max drawdown exceeds 53 %, reflecting sizable price swings. The beta of 0.90 points to lower systematic risk than the market, while decreasing volume may limit short‑term liquidity. The company’s debt‑to‑equity ratio of 4.08 is elevated, but strong operating cash flow and a free cash flow generation of £3.39 bn support balance‑sheet resilience. The sector’s regulatory environment and broad geographic exposure introduce moderate regulatory and geographic risks. Overall, the combination of a sizable valuation gap, solid earnings, and a sustainable dividend outweighs the technical bearish trend in the medium‑term view. Investors should therefore consider a measured entry, capitalising on upside potential while monitoring technical levels.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering near resistance at 2,364
- decreasing trading volume
- bullish MACD signal despite long‑term bearish SMAs
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- valuation upside >45% versus DCF fair value
- sustainable dividend yield of 3.66% with low payout
- strong FY‑2026 performance delivering 22% total return
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- significant valuation gap and low P/E relative to peers
- diversified global portfolio reducing concentration risk
- low beta and robust cash‑flow generation supporting stability
Key Metrics & Analysis
Financial Health
Revenue Growth-33.40%
Profit Margin94.84%
P/E Ratio4.3
ROE19.08%
ROA11.66%
Debt/Equity4.08
P/B Ratio0.8
Op. Cash Flow£998.0M
Free Cash Flow£3.4B
Industry P/E16.8
Technical Analysis
TrendBearish
RSI50.3
Support£2,043.00
Resistance£2,364.00
MA 20£2,218.10
MA 50£2,465.74
MA 200£3,259.66
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value£4,371.45
Target Price£3,362.20
Upside/Downside45.61%
GradeUndervalued
TypeBlend
Dividend Yield3.66%
Risk Assessment
Beta0.90
Volatility58.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.